This randomized , double-blind , placebo-controlled trial evaluated MR calcifediol in CKD subjects ( n = @ ) with plasma intact parathyroid hormone ( iPTH ) > @ pg/ml and serum total @-hydroxyvitamin D < @ ng/ml .